{"transactions":[{"id":734151,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-17T21:10:15.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":false,"shares":13040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested in full on the date of the 2026 annual stockholder meeting."}],"balance_after":0,"derivative":{"exercise_price":1.07,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":13040},"source":{"system":"sec-edgar","filing":"0001628280-26-043987","document":"wk-form4_1781730613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000162828026043987/wk-form4_1781730613.xml","form_type":"4"}},{"id":734150,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-17T21:10:15.000Z","date":"2026-06-15","kind":"exercise","planned":false,"acquired":false,"shares":6460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested in full on the date of the 2026 annual stockholder meeting."}],"balance_after":13040,"derivative":{"exercise_price":1.07,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":6460},"source":{"system":"sec-edgar","filing":"0001628280-26-043987","document":"wk-form4_1781730613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000162828026043987/wk-form4_1781730613.xml","form_type":"4"}},{"id":734149,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T21:10:15.000Z","date":"2026-06-17","kind":"sale","planned":false,"acquired":false,"shares":13040,"price":2.325,"value":30318.0,"ownership":{"direct":true},"balance_after":35500,"source":{"system":"sec-edgar","filing":"0001628280-26-043987","document":"wk-form4_1781730613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000162828026043987/wk-form4_1781730613.xml","form_type":"4"}},{"id":734148,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T21:10:15.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":true,"shares":13040,"price":1.07,"value":13952.8,"ownership":{"direct":true},"balance_after":48540,"source":{"system":"sec-edgar","filing":"0001628280-26-043987","document":"wk-form4_1781730613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000162828026043987/wk-form4_1781730613.xml","form_type":"4"}},{"id":734147,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T21:10:15.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":12800,"price":2.326,"value":29772.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $2.305 to $2.345. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":35500,"source":{"system":"sec-edgar","filing":"0001628280-26-043987","document":"wk-form4_1781730613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000162828026043987/wk-form4_1781730613.xml","form_type":"4"}},{"id":734146,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T21:10:15.000Z","date":"2026-06-15","kind":"sale","planned":false,"acquired":false,"shares":6460,"price":2.345,"value":15148.7,"ownership":{"direct":true},"balance_after":48300,"source":{"system":"sec-edgar","filing":"0001628280-26-043987","document":"wk-form4_1781730613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000162828026043987/wk-form4_1781730613.xml","form_type":"4"}},{"id":734145,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T21:10:15.000Z","date":"2026-06-15","kind":"exercise","planned":false,"acquired":true,"shares":6460,"price":1.07,"value":6912.2,"ownership":{"direct":true},"balance_after":54760,"source":{"system":"sec-edgar","filing":"0001628280-26-043987","document":"wk-form4_1781730613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000162828026043987/wk-form4_1781730613.xml","form_type":"4"}},{"id":747974,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:30:12.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":53250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in full on the earlier of the first anniversary of the date of grant or the 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":53250,"derivative":{"exercise_price":2.29,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":53250},"source":{"system":"sec-edgar","filing":"0001628280-26-041272","document":"wk-form4_1780691403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000162828026041272/wk-form4_1780691403.xml","form_type":"4"}},{"id":747973,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:30:12.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in full on the earlier of the first anniversary of the date of grant or the 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":48300,"source":{"system":"sec-edgar","filing":"0001628280-26-041272","document":"wk-form4_1780691403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000162828026041272/wk-form4_1780691403.xml","form_type":"4"}},{"id":768047,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-21T20:13:40.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":10539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2027 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":10539,"derivative":{"exercise_price":5.08,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":10539},"source":{"system":"sec-edgar","filing":"0001706400-26-000002","document":"form4-05212026_080536.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000170640026000002/form4-05212026_080536.xml","form_type":"4"}},{"id":1121361,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-05T20:51:20.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":19500,"derivative":{"exercise_price":1.07,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001576885-25-000078","document":"wk-form4_1749156630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000157688525000078/wk-form4_1749156630.xml","form_type":"4"}},{"id":1121360,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:51:20.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual\nstockholder meeting, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":12800,"source":{"system":"sec-edgar","filing":"0001576885-25-000078","document":"wk-form4_1749156630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000157688525000078/wk-form4_1749156630.xml","form_type":"4"}},{"id":1129290,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-30T23:29:26.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":201857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2026 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":201857,"derivative":{"exercise_price":0.3598,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":201857},"source":{"system":"sec-edgar","filing":"0001415889-25-015057","document":"form4-05302025_110521.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000141588925015057/form4-05302025_110521.xml","form_type":"4"}},{"id":1484981,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:46:33.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 10, 2025 or the 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.62,"expiration_date":"2034-06-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001576885-24-000080","document":"wk-form4_1718052386.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000157688524000080/wk-form4_1718052386.xml","form_type":"4"}},{"id":1503735,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2024-05-23T20:51:39.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":47693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2025 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":47693,"derivative":{"exercise_price":1.28,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":47693},"source":{"system":"sec-edgar","filing":"0001415889-24-014309","document":"form4-05232024_080531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000141588924014309/form4-05232024_080531.xml","form_type":"4"}},{"id":1863972,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-07T21:43:47.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 6, 2024 or the 2024 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":5.2,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001576885-23-000035","document":"wk-form4_1686174215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000157688523000035/wk-form4_1686174215.xml","form_type":"4"}},{"id":1876630,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-05-26T20:35:40.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of:  (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":24000,"derivative":{"exercise_price":1,"expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-23-032568","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919123032568/doc4.xml","form_type":"4"}},{"id":2067963,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Grant (right to buy)","published_at":"2023-01-05T00:41:04.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date and shall vest and become immediately exercisable prior to the effectiveness of a change in control."}],"balance_after":50000,"derivative":{"exercise_price":5.46,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-001431","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919123001431/doc4.xml","form_type":"4"}},{"id":2251489,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-05-31T20:32:10.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of:  (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":24000,"derivative":{"exercise_price":1.76,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-22-032837","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919122032837/doc4.xml","form_type":"4"}},{"id":2691363,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-05-28T21:56:46.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":33836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/36 of the total shares monthly beginning on June 27, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":33836,"derivative":{"exercise_price":13.83,"expiration_date":"2031-05-26","underlying":"Common Stock","underlying_shares":33836},"source":{"system":"sec-edgar","filing":"0001209191-21-036621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919121036621/doc4.xml","form_type":"4"}},{"id":3576640,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Common Stock","published_at":"2019-03-27T21:17:20.000Z","date":"2019-03-26","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 50% of the shares on March 26, 2020 and 50% of the shares on March 26, 2021, subject to the reporting\nperson's continuous service."}],"balance_after":31688,"source":{"system":"sec-edgar","filing":"0001209191-19-021441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919119021441/doc4.xml","form_type":"4"}},{"id":3650173,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-19T22:05:30.000Z","date":"2019-02-15","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to Rule 10b5-1 Plan adopted November 9, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest and become exercisable on May 10, 2018 and 1/48th of the shares subject to the stock option vest and become exercisable each full month thereafter."}],"balance_after":109666,"derivative":{"exercise_price":14.3,"expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-19-011175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919119011175/doc4.xml","form_type":"4"}},{"id":3650172,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Common Stock","published_at":"2019-02-19T22:05:30.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":5909,"price":40,"value":236360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to Rule 10b5-1 Plan adopted November 9, 2018."}],"balance_after":21688,"source":{"system":"sec-edgar","filing":"0001209191-19-011175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919119011175/doc4.xml","form_type":"4"}},{"id":3650171,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Common Stock","published_at":"2019-02-19T22:05:30.000Z","date":"2019-02-15","kind":"exercise","acquired":true,"shares":4000,"price":14.3,"value":57200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to Rule 10b5-1 Plan adopted November 9, 2018."}],"balance_after":27597,"source":{"system":"sec-edgar","filing":"0001209191-19-011175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919119011175/doc4.xml","form_type":"4"}},{"id":3668249,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-08T21:23:32.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":24625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the stock option vest and become exercisable each month following February 6, 2019, subject to the reporting person's continuous service."}],"balance_after":24625,"derivative":{"exercise_price":38.47,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":24625},"source":{"system":"sec-edgar","filing":"0001209191-19-008508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919119008508/doc4.xml","form_type":"4"}},{"id":3668248,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Common Stock","published_at":"2019-02-08T21:23:32.000Z","date":"2019-02-06","kind":"grant","acquired":false,"shares":12313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in four equal annual installments on each of the first, second, third and fourth anniversaries of the grant date, subject\nto the reporting person's continuous service."}],"balance_after":23597,"source":{"system":"sec-edgar","filing":"0001209191-19-008508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919119008508/doc4.xml","form_type":"4"}},{"id":3668247,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Common Stock","published_at":"2019-02-08T21:23:32.000Z","date":"2019-02-06","kind":"tax_withholding","acquired":false,"shares":1216,"price":38.47,"value":46779.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to cover tax obligation from settlement of vested restricted stock units."}],"balance_after":11284,"source":{"system":"sec-edgar","filing":"0001209191-19-008508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919119008508/doc4.xml","form_type":"4"}},{"id":3931044,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-17T00:41:56.000Z","date":"2018-05-15","kind":"exercise","acquired":false,"shares":16334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to Rule 10b5-1 Plan adopted March 9, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest and become exercisable on May 10, 2018 and 1/48th of the shares subject to the stock option vest and become exercisable each full month thereafter."}],"balance_after":113666,"derivative":{"exercise_price":14.3,"expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":16334},"source":{"system":"sec-edgar","filing":"0001209191-18-030727","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919118030727/doc4.xml","form_type":"4"}},{"id":3931043,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Common Stock","published_at":"2018-05-17T00:41:56.000Z","date":"2018-05-15","kind":"sale","acquired":false,"shares":16334,"price":45.02,"value":735356.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to Rule 10b5-1 Plan adopted March 9, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in Column 4 is a weighted average sale price. The prices actually received ranged from $45.00 to $45.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range"}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001209191-18-030727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919118030727/doc4.xml","form_type":"4"}},{"id":3931042,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Common Stock","published_at":"2018-05-17T00:41:56.000Z","date":"2018-05-15","kind":"exercise","acquired":true,"shares":16334,"price":14.3,"value":233576.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to Rule 10b5-1 Plan adopted March 9, 2018."}],"balance_after":28834,"source":{"system":"sec-edgar","filing":"0001209191-18-030727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919118030727/doc4.xml","form_type":"4"}},{"id":3942676,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Common Stock","published_at":"2018-05-09T00:18:40.000Z","date":"2018-05-08","kind":"sale","acquired":false,"shares":1544,"price":40.15,"value":61991.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to Rule 10b5-1 Plan adopted March 9, 2018."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001209191-18-028714","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919118028714/doc4.xml","form_type":"4"}},{"id":4070556,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-08T22:44:23.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the stock option vest and become exercisable each month following February 6, 2018."}],"balance_after":25000,"derivative":{"exercise_price":35.8,"expiration_date":"2025-02-06","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-008510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919118008510/doc4.xml","form_type":"4"}},{"id":4070555,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Common Stock","published_at":"2018-02-08T22:44:23.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest in four equal annual installments on each of the first, second, third and fourth anniversaries of the grant date, subject to the reporting person's continuous service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,544 shares issued on November 30, 2017 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":14044,"source":{"system":"sec-edgar","filing":"0001209191-18-008510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919118008510/doc4.xml","form_type":"4"}},{"id":4324967,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":37267,"kind":"person","name":"Porter Derrell","position":1,"cik":"0001706400","reported_name":"Porter Derrell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Global Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-05-11T23:40:21.000Z","date":"2017-05-10","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest and become exercisable on May 10, 2018 and 1/48th of the shares subject to the stock option vest and become exercisable each full month thereafter."}],"balance_after":130000,"derivative":{"exercise_price":14.3,"expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-17-031664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706400/000120919117031664/doc4.xml","form_type":"4"}}]}